# Evaluation on the Safety of Ticagrelor Among Chinese ACS Patients

> **NCT02430493** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1066 (actual)

## Conditions studied

- Acute Coronary Syndrome (ACS)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02430493
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-28
- **Primary completion:** 2017-03-29
- **Final completion:** 2017-03-29
- **Target enrollment:** 1066 (ACTUAL)
- **Last updated:** 2018-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02430493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02430493, "Evaluation on the Safety of Ticagrelor Among Chinese ACS Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02430493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*